FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3171595980> ?p ?o ?g. }

• W3171595980 endingPage "174233" @default.
• W3171595980 startingPage "174233" @default.
• W3171595980 abstract "Dihydroorotate dehydrogenase (DHODH) is rate-limiting enzyme in biosynthesis of pyrimidone which catalyzes the oxidation of dihydro-orotate to orotate. Orotate is utilized in the biosynthesis of uridine-monophosphate. DHODH inhibitors have shown promise as antiviral agent against Cytomegalovirus, Ebola, Influenza, Epstein Barr and Picornavirus. Anti-SARS-CoV-2 action of DHODH inhibitors are also coming up. In this review, we have reviewed the safety and efficacy of approved DHODH inhibitors (leflunomide and teriflunomide) against COVID-19. In target-centered in silico studies, leflunomide showed favorable binding to active site of MPro and spike: ACE2 interface. In artificial-intelligence/machine-learning based studies, leflunomide was among the top 50 ligands targeting spike: ACE2 interaction. Leflunomide is also found to interact with differentially regulated pathways [identified by KEGG (Kyoto Encyclopedia of Genes and Genomes) and reactome pathway analysis of host transcriptome data] in cogena based drug-repurposing studies. Based on GSEA (gene set enrichment analysis), leflunomide was found to target pathways enriched in COVID-19. In vitro, both leflunomide (EC50 41.49 ± 8.8 μmol/L) and teriflunomide (EC50 26 μmol/L) showed SARS-CoV-2 inhibition. In clinical studies, leflunomide showed significant benefit in terms of decreasing the duration of viral shredding, duration of hospital stay and severity of infection. However, no advantage was seen while combining leflunomide and IFN alpha-2a among patients with prolonged post symptomatic viral shredding. Common adverse effects of leflunomide were hyperlipidemia, leucopenia, neutropenia and liver-function alteration. Leflunomide/teriflunomide may serve as an agent of importance to achieve faster virological clearance in COVID-19, however, findings needs to be validated in bigger sized placebo controlled studies." @default.
• W3171595980 created "2021-06-22" @default.
• W3171595980 creator A5020993226 @default.
• W3171595980 creator A5022950768 @default.
• W3171595980 creator A5024558581 @default.
• W3171595980 creator A5043463086 @default.
• W3171595980 creator A5048624729 @default.
• W3171595980 creator A5049304752 @default.
• W3171595980 creator A5058888417 @default.
• W3171595980 creator A5060225297 @default.
• W3171595980 creator A5069752277 @default.
• W3171595980 creator A5071203100 @default.
• W3171595980 creator A5079796547 @default.
• W3171595980 creator A5082118632 @default.
• W3171595980 creator A5086188645 @default.
• W3171595980 date "2021-09-01" @default.
• W3171595980 modified "2023-10-06" @default.
• W3171595980 title "Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review" @default.
• W3171595980 cites W1962468650 @default.
• W3171595980 cites W1969575774 @default.
• W3171595980 cites W2027607998 @default.
• W3171595980 cites W2027608934 @default.
• W3171595980 cites W2031904443 @default.
• W3171595980 cites W2045773333 @default.
• W3171595980 cites W2048431634 @default.
• W3171595980 cites W2133789608 @default.
• W3171595980 cites W2159498232 @default.
• W3171595980 cites W2228301361 @default.
• W3171595980 cites W2239206990 @default.
• W3171595980 cites W2326091185 @default.
• W3171595980 cites W2618083329 @default.
• W3171595980 cites W2774279936 @default.
• W3171595980 cites W2783323413 @default.
• W3171595980 cites W2796794885 @default.
• W3171595980 cites W2888474837 @default.
• W3171595980 cites W2942927606 @default.
• W3171595980 cites W2967237262 @default.
• W3171595980 cites W2972615080 @default.
• W3171595980 cites W3016626550 @default.
• W3171595980 cites W3025553239 @default.
• W3171595980 cites W3030121249 @default.
• W3171595980 cites W3032164206 @default.
• W3171595980 cites W3033227115 @default.
• W3171595980 cites W3035895822 @default.
• W3171595980 cites W3038423562 @default.
• W3171595980 cites W3043159370 @default.
• W3171595980 cites W3045646492 @default.
• W3171595980 cites W3046295569 @default.
• W3171595980 cites W3046717686 @default.
• W3171595980 cites W3047125225 @default.
• W3171595980 cites W3047284590 @default.
• W3171595980 cites W3047350847 @default.
• W3171595980 cites W3080418884 @default.
• W3171595980 cites W3081388769 @default.
• W3171595980 cites W3082693581 @default.
• W3171595980 cites W3087084553 @default.
• W3171595980 cites W3087234540 @default.
• W3171595980 cites W3089310389 @default.
• W3171595980 cites W3093109617 @default.
• W3171595980 cites W3094209984 @default.
• W3171595980 cites W3119151321 @default.
• W3171595980 cites W3120108340 @default.
• W3171595980 cites W3126436471 @default.
• W3171595980 cites W3130654345 @default.
• W3171595980 cites W3131302981 @default.
• W3171595980 cites W3138995283 @default.
• W3171595980 doi "https://doi.org/10.1016/j.ejphar.2021.174233" @default.
• W3171595980 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8180448" @default.
• W3171595980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34111397" @default.
• W3171595980 hasPublicationYear "2021" @default.
• W3171595980 type Work @default.
• W3171595980 sameAs 3171595980 @default.
• W3171595980 citedByCount "22" @default.
• W3171595980 countsByYear W31715959802022 @default.
• W3171595980 countsByYear W31715959802023 @default.
• W3171595980 crossrefType "journal-article" @default.
• W3171595980 hasAuthorship W3171595980A5020993226 @default.
• W3171595980 hasAuthorship W3171595980A5022950768 @default.
• W3171595980 hasAuthorship W3171595980A5024558581 @default.
• W3171595980 hasAuthorship W3171595980A5043463086 @default.
• W3171595980 hasAuthorship W3171595980A5048624729 @default.
• W3171595980 hasAuthorship W3171595980A5049304752 @default.
• W3171595980 hasAuthorship W3171595980A5058888417 @default.
• W3171595980 hasAuthorship W3171595980A5060225297 @default.
• W3171595980 hasAuthorship W3171595980A5069752277 @default.
• W3171595980 hasAuthorship W3171595980A5071203100 @default.
• W3171595980 hasAuthorship W3171595980A5079796547 @default.
• W3171595980 hasAuthorship W3171595980A5082118632 @default.
• W3171595980 hasAuthorship W3171595980A5086188645 @default.
• W3171595980 hasBestOaLocation W31715959801 @default.
• W3171595980 hasConcept C181199279 @default.
• W3171595980 hasConcept C203014093 @default.
• W3171595980 hasConcept C2775905006 @default.
• W3171595980 hasConcept C2776036978 @default.
• W3171595980 hasConcept C2777575956 @default.
• W3171595980 hasConcept C2777703276 @default.
• W3171595980 hasConcept C2779865431 @default.
• W3171595980 hasConcept C2780640218 @default.

• next